Pharmaceutical

FDA biosimilar approvals set for record-breaking year amid US pricing reforms

A record number of biosimilars were approved by the FDA in 2024, with 2025 set to be another stellar year.

May 18, 2025 - 06:00
FDA biosimilar approvals set for record-breaking year amid US pricing reforms
A record number of biosimilars were approved by the FDA in 2024, with 2025 set to be another stellar year.
Read the original article

Tags:

Previous Article

Revamping US pharma manufacturing: Trump’s executive order faces industry doubts

Next Article

AGC Biologics and Quell to progress Treg cell therapy development

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

New Senate deal would ban some facility fees, reform hospital contracting

New Senate deal would ban some facility fees, reform ho...

Sep 14, 2023

Beyond approval: Patients pursue alternate paths to get rare disease treatments

Beyond approval: Patients pursue alternate paths to get...

Feb 28, 2024

STAT+: With Biden finalizing an Apple Watch ban, Apple needs to decide its future in health

STAT+: With Biden finalizing an Apple Watch ban, Apple ...

Dec 27, 2023